Wonjong Jin

9PUBLICATIONS
57CO-AUTHORS
Radiation therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.

|May 01, 2026
Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases.

|Jan 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.

Caroline P Kerr, Won Jong Jin, Peng Liu

|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Sep 18, 2024
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Justin C Jagodinsky, Jessica M Vera, Won Jong Jin

|Sep 20, 2023
ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models.

Won Jong Jin, Luke M Zangl, Meredith Hyun

Pageof 2

Frequent Collaborators

8 joint publications

Zachary S Morris

4 joint publications

Caroline P Kerr

3 joint publications

Amanda G Shea

3 joint publications

Jamey Weichert